DFTX 10-Q: SEC filing

Definium Therapeutics

Filed with the SEC on Nov 9, 2026 · accession 0001193125-26-453626

DFTX filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. Definium Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, equity compensation activity, and debt arrangements. The stock moved +6.4% by the first close after the filing.

Summary of the filing

Definium Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, equity compensation activity, and debt arrangements. The filing contains no single material corporate event.

For details, click here →How to read a 10-Q →

Key details

Lender under amended term loan and security agreementK2 HealthVentures LLC

How DFTX stock reacted

Close before

$33.27

Nov 6, 2026

First close after

+6.37%

$35.39

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for DFTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DFTX?

Click here

Frequently asked questions

What did DFTX file with the SEC on Nov 9, 2026?

DFTX filed a 10-Q (SEC filing). Definium Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, equity compensation activity, and debt arrangements. The filing contains no single material corporate event.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did DFTX stock react to this filing?

DFTX closed at $33.27 before the filing and $35.39 on Nov 9, 2026 (+6.37%).

Other DFTX SEC filings

Get alerts when DFTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

DFTX overview DFTX analysis DFTX news Latest SEC filings